Financial conflicts of interest and outcomes and quality of systematic reviews

Camilla Hansen, Andreas Lundh, Kristine Rasmussen, Peter C Gøtzsche, Asbjørn Hrõbjartsson

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

78 Downloads (Pure)

Resumé

This is a protocol for a Cochrane Review (Methodology). The objectives are as follows:

The primary objectives are to investigate to what degree:
- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with effect size estimate; and
- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with conclusions that are favourable to the sponsor.

The secondary objective is to investigate to what degree:
- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with the methodological quality of systematic reviews as presented by the reviews.
OriginalsprogEngelsk
ArtikelnummerMR000047
TidsskriftCochrane Database of Systematic Reviews
Vol/bind2017
Udgave nummer12
Antal sider9
ISSN1361-6137
DOI
StatusUdgivet - 2017

Citer dette

@article{4fe25d7167974f8d9ecbab4a2486fd6d,
title = "Financial conflicts of interest and outcomes and quality of systematic reviews",
abstract = "This is a protocol for a Cochrane Review (Methodology). The objectives are as follows:The primary objectives are to investigate to what degree:- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with effect size estimate; and- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with conclusions that are favourable to the sponsor.The secondary objective is to investigate to what degree:- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with the methodological quality of systematic reviews as presented by the reviews.",
author = "Camilla Hansen and Andreas Lundh and Kristine Rasmussen and G{\o}tzsche, {Peter C} and Asbj{\o}rn Hr{\~o}bjartsson",
year = "2017",
doi = "10.1002/14651858.MR000047",
language = "English",
volume = "2017",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "John Wiley & Sons Ltd",
number = "12",

}

Financial conflicts of interest and outcomes and quality of systematic reviews. / Hansen, Camilla; Lundh, Andreas; Rasmussen, Kristine; Gøtzsche, Peter C; Hrõbjartsson, Asbjørn.

I: Cochrane Database of Systematic Reviews, Bind 2017, Nr. 12, MR000047, 2017.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Financial conflicts of interest and outcomes and quality of systematic reviews

AU - Hansen, Camilla

AU - Lundh, Andreas

AU - Rasmussen, Kristine

AU - Gøtzsche, Peter C

AU - Hrõbjartsson, Asbjørn

PY - 2017

Y1 - 2017

N2 - This is a protocol for a Cochrane Review (Methodology). The objectives are as follows:The primary objectives are to investigate to what degree:- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with effect size estimate; and- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with conclusions that are favourable to the sponsor.The secondary objective is to investigate to what degree:- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with the methodological quality of systematic reviews as presented by the reviews.

AB - This is a protocol for a Cochrane Review (Methodology). The objectives are as follows:The primary objectives are to investigate to what degree:- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with effect size estimate; and- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with conclusions that are favourable to the sponsor.The secondary objective is to investigate to what degree:- funding of systematic reviews by drug, device, and imaging companies and authors' other financial conflicts of interest are associated with the methodological quality of systematic reviews as presented by the reviews.

U2 - 10.1002/14651858.MR000047

DO - 10.1002/14651858.MR000047

M3 - Journal article

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 12

M1 - MR000047

ER -